-
-
-
-
-
-
-
Ocean Biomedical (NASDAQ: OCEA) Extends Patent Rights for Breakthrough Idiopathic Pulmonary Fibrosis Discovery To Europe
-
-
-
-
-
-
-
Ocean Biomedical (OCEA) Announces Notice of Allowance for U.S. Patent Application for Breakthrough Pulmonary Fibrosis Treatments Issued to Scientific Co-founder Dr. Jack A. Elias.
-
-
-
-
-
-
-
Ocean Biomedical (OCEA) Details Novel Malaria Therapeutic Discoveries at the NIH Laboratory of Malaria Vaccinology and Immunology on PfGARP’s Potential as a Highly Effective Vaccine Target and Thera
-
-
-
-
-
-
-
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.33%
-
-
-
-
-
-
-
Form 425 Aesther Healthcare Acqui Filed by: Aesther Healthcare Acquisition Corp.
-
-
-
-
-
-
-
Ocean Biomedical (AEHAU) Reports Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other Cancers
-
-
-
-
-
-
-
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%, Anno
-
1,157,749 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

